{"disease":{"id":"human-immunodeficiency-virus-hiv-infection","name":"human immunodeficiency virus hiv infection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04772469","title":"Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men","phase":"NA","overall_status":"COMPLETED","enrollment_count":934,"lead_sponsor_name":"University of California, San Francisco","has_results":true},{"nct_id":"NCT03618511","title":"Interventions to Improve HIV Antiretroviral Therapy Adherence","phase":"NA","overall_status":"COMPLETED","enrollment_count":914,"lead_sponsor_name":"University of Michigan","has_results":false},{"nct_id":"NCT01231516","title":"A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":724,"lead_sponsor_name":"ViiV Healthcare","has_results":true},{"nct_id":"NCT02831764","title":"An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Participants (Gemini 2)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":722,"lead_sponsor_name":"ViiV Healthcare","has_results":true},{"nct_id":"NCT02831673","title":"An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":719,"lead_sponsor_name":"ViiV Healthcare","has_results":true},{"nct_id":"NCT02965014","title":"NC Young Women's CoOp","phase":"NA","overall_status":"TERMINATED","enrollment_count":652,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT02951052","title":"Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":618,"lead_sponsor_name":"ViiV Healthcare","has_results":true},{"nct_id":"NCT05452616","title":"Same-day Versus Rapid ART Initiation in HIV-positive Individuals Presenting With Symptoms of Tuberculosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":610,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT03310515","title":"Incidence of Human Immunodeficiency Virus-1 (HIV-1) Infection in HIV-1 Uninfected High Risk Men Who Have Sex With Men","phase":"","overall_status":"COMPLETED","enrollment_count":578,"lead_sponsor_name":"ViiV Healthcare","has_results":false},{"nct_id":"NCT07266831","title":"A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":570,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT01910402","title":"A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":499,"lead_sponsor_name":"ViiV Healthcare","has_results":true},{"nct_id":"NCT07209917","title":"Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India","phase":"NA","overall_status":"RECRUITING","enrollment_count":420,"lead_sponsor_name":"University of California, Irvine","has_results":false},{"nct_id":"NCT07039682","title":"Empowering Knowledge, Self-Testing & Resilience Through Innovative Methods for HIV","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Universitas Sebelas Maret","has_results":false},{"nct_id":"NCT02120352","title":"A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":309,"lead_sponsor_name":"ViiV Healthcare","has_results":true},{"nct_id":"NCT04768517","title":"HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral Therapy","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT06886971","title":"Strategies to AchieVe Viral Suppression for Youth With HIV","phase":"NA","overall_status":"RECRUITING","enrollment_count":288,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT01448707","title":"A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":274,"lead_sponsor_name":"Janssen-Cilag International NV","has_results":true},{"nct_id":"NCT07370649","title":"Long-Acting Cabotegravir and Rilpivirine in People Living With HIV-1 Subtype A6: A Real-World Retrospective Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":250,"lead_sponsor_name":"Pomeranian Medical University Szczecin","has_results":false},{"nct_id":"NCT01641809","title":"Dose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Maintenance by GSK1265744 Plus Rilpivirine","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":244,"lead_sponsor_name":"ViiV Healthcare","has_results":true},{"nct_id":"NCT00046176","title":"A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"ViiV Healthcare","has_results":false},{"nct_id":"NCT01536873","title":"Dolutegravir Expanded Access Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"ViiV Healthcare","has_results":false},{"nct_id":"NCT07476339","title":"REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"CAN Community Health","has_results":false},{"nct_id":"NCT00044577","title":"New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":166,"lead_sponsor_name":"ViiV Healthcare","has_results":false},{"nct_id":"NCT06891066","title":"A Study of Islatravir (ISL) and Ulonivirine (ULO) Once Weekly (QW) in Virologically Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8591B-060)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT02741557","title":"Bioequivalence Study of a Fixed-dose Combination (FDC) of Dolutegravir (DTG) and Rilpivirine (RPV)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":118,"lead_sponsor_name":"ViiV Healthcare","has_results":false},{"nct_id":"NCT02178592","title":"Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":113,"lead_sponsor_name":"ViiV Healthcare","has_results":true},{"nct_id":"NCT01803074","title":"Study to Evaluate a HIV Drug for the Treatment of HIV Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":107,"lead_sponsor_name":"ViiV Healthcare","has_results":true},{"nct_id":"NCT03729778","title":"Impact of HIV-1 and Aging on Mucosal Vaccine Responses","phase":"EARLY_PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"VA Eastern Colorado Health Care System","has_results":false},{"nct_id":"NCT04375800","title":"Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":84,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT03231943","title":"GSK3640254 First Time in Human (FTIH) Study in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"ViiV Healthcare","has_results":true},{"nct_id":"NCT05328583","title":"A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral HRS5685 in Healthy Subjects","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":64,"lead_sponsor_name":"RetroLead (Shanghai) BioPharma Co., Ltd.","has_results":false},{"nct_id":"NCT00071760","title":"Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":59,"lead_sponsor_name":"ViiV Healthcare","has_results":true},{"nct_id":"NCT03800394","title":"Pharmacokinetics of Intracellular TFV-DP and FTC-TP in HIV-infected Adolescents","phase":"","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"University of Florida","has_results":false},{"nct_id":"NCT03314064","title":"Phase 4 Study of Dolutegravir (DTG) in Russian Federation","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"ViiV Healthcare","has_results":false},{"nct_id":"NCT04223804","title":"A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With Human Immunodeficiency Virus (HIV)-1","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"AbbVie","has_results":false},{"nct_id":"NCT03368053","title":"Long-term Immunogenicity of the HIV gp120-NefTat/AS01B Vaccine (GSK SB732461)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT03045861","title":"Safety and Efficacy Study of GSK2838232 in Human Immunodeficiency Virus (HIV)-1 Infected Adults","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT06430905","title":"Safety, Reactogenicity and Immunogenicity of HB-502 and HB-501 Versus Placebo in People With HIV on Suppressive ART","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":30,"lead_sponsor_name":"Hookipa Biotech GmbH","has_results":false},{"nct_id":"NCT03234036","title":"A Two-part Study to Compare a Tablet and Capsule Formulation of GSK2838232 With and Without Food, and to Assess the Safety and Drug Levels of Repeated Once-daily Doses of GSK2838232 Without Ritonavir","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01031472","title":"A Study to Assess Relative Bioavailability and Food Effect of New Formulations of GSK2248761","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"ViiV Healthcare","has_results":false},{"nct_id":"NCT02478463","title":"Pharmacokinetic Study of Cabotegravir Long-acting in Healthy Adult Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"ViiV Healthcare","has_results":true},{"nct_id":"NCT01068925","title":"Drug Interaction Study Between GSK1349572 and Tipranavir/Ritonavir in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"ViiV Healthcare","has_results":false},{"nct_id":"NCT05458102","title":"Drug-Drug Interaction Study of Vesatolimod in Adults With HIV-1 Who Have Very Low or Undetectable Virus Levels","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":18,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT02354937","title":"Pharmacokinetics Study of GSK1265744 in Subjects With Severe Renal Impairment","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"ViiV Healthcare","has_results":false},{"nct_id":"NCT01231529","title":"GSK1349572 Hepatic Impairment Study","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"ViiV Healthcare","has_results":false},{"nct_id":"NCT03149848","title":"Effect of Rifabutin on the Pharmacokinetics of Oral Cabotegravir in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"ViiV Healthcare","has_results":true},{"nct_id":"NCT02715700","title":"Effects of Doravirine (MK-1439) on Methadone Pharmacokinetics in Methadone-Maintained Participants (MK-1439-045)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT01195974","title":"A Study to Evaluate the Pharmacokinetics of an Oral Contraceptive When Co-administered With GSK2248761 in Healthy Adult Female Subjects.","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":13,"lead_sponsor_name":"ViiV Healthcare","has_results":false},{"nct_id":"NCT04515641","title":"Single-Dose Islatravir in Moderate Hepatic Impairment (MK-8591-030)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT03667547","title":"Safety, Tolerability, and Pharmacokinetics of Raltegravir (MK-0518) in Healthy Japanese Male Participants (MK-0518-851)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}